Pam Rajendran Taub, MD

• Assistant Professor of Medicine
• University of California - San Diego
• Division of Cardiology
• San Diego, California

Because this process is inefficient bacteria jacuzzi order discount zyvox on line, one polymerase protein is translated for every 200 to 300 molecules of core polypeptides antibiotics human bite purchase generic zyvox online. During chronic hepatitis bacteria 4 in urinalysis purchase 600 mg zyvox free shipping, accumulation of the L surface protein­containing particles has been associated with the pathologic phenotype of ground-glass hepatocytes 2012 antimicrobial susceptibility testing standards 600 mg zyvox buy mastercard. The phases of chronic hepatitis B are in flux antibiotic resistance global statistics cheap zyvox online, with the newest guidelines delineating phases based on serologic markers. Termination of virus replication is associated in most patients with biochemical and histologic regression of inflammatory activity. This limits the liver injury during acute infection but, as a consequence, prolongs viral clearance. Other surface antigens that stimulate antibody responses include the pre-S1 and pre-S2 antigens. Mutation in the S gene usually occurs in the "a" determinant, which allows the virus to escape antibody neutralization. In >95% of immunocompetent adults the immune response is vigorous, polyclonal, and multispecific and results in acute, self-limited hepatitis with reduction of viral load and the development of long-lasting humoral and cellular immunity. Persistent infection is associated with necroinflammatory activity, which eventually leads to cirrhosis. However, a hallmark of acute hepatitis B is failure to induce an innate cytokine response mediated by pattern recognition receptors. These lesions are characterized as exhibiting different levels of cell differentiation. Cirrhosis is the result of years of inflammation and associated repair processes, during which there is considerable cell killing and repeated hepatocyte regeneration. In all types of liver damage, there is evidence of enhanced production of free radicals or significant decrease of antioxidant defense, or both. For infections acquired between the ages of 6 months and 5 years, the risk of chronic infection is between 20% and 60%, and for infections acquired by immunocompetent adults the risk is approximately 5%. In the United States the estimated number of new symptomatic infections per year was more than 10 per 100,000 in the mid-1980s, whereas after the adoption of universal vaccination for infants and "catch-up" vaccination for older children in 1991, this number was estimated to be about 1. In high- and intermediate-endemicity areas, such as sub-Saharan Africa and South East Asia, the predominant route of transmission is perinatal or horizontal during childhood. During the acute phase, manifestations range from subclinical or anicteric hepatitis to icteric hepatitis and, in some cases, fulminant hepatitis. Physical signs include jaundice (present in almost all patients) and tender hepatomegaly. Symptomatic hepatitis rarely develops in children younger than 1 year, in 10% of children younger than 5 years, and between 30% and 80% of adults. The symptoms and jaundice generally disappear in 1 month, but some patients have prolonged fatigue even after resolution of the elevated serum aminotransferases. The serum bilirubin concentration may be normal in patients with anicteric hepatitis. Rates of progression to chronic disease are similar whether or not there is symptomatic acute disease. Many patients with chronic hepatitis B are not diagnosed as a result of follow-up after a case of icteric illness or due to specific symptoms, but rather as a result of incidental elevations in serum aminotransferases or due to membership in a specific risk category. Other less common symptoms include nausea, right upper quadrant tenderness, anorexia, myalgias, and arthralgias. Symptoms often do not correlate with severity of disease, levels of serum aminotransferases, or hepatic injury on liver biopsy. The presence of jaundice, splenomegaly, ascites, encephalopathy, or pedal edema suggests cirrhosis. In some patients this results in repopulation of the viral species with a new variant. Cirrhosis should be suspected if there is evidence of hypersplenism, manifested as decreased platelet count, or impaired hepatic synthetic function, indicated by hypoalbuminemia, hyperbilirubinemia, or decreased albumin. Similar to the range of findings observed in other laboratory tests, findings on liver biopsy range from minimal inflammation to cirrhosis. Fattovich and colleagues71 found that 30% of patients with moderate, chronic active hepatitis developed cirrhosis on histology after 6 years, whereas 50% of patients with severe, chronic active hepatitis (bridging necrosis) developed cirrhosis on histology after 4 years. An estimated 800,000 new cases occur each year, with chronic hepatitis B accounting for 18% (Europe) to 65% (China) of total cases. It is a vasculitis of small- to medium-size arteries and typically presents with fever, rash, hypertension, eosinophilia, abdominal pain, renal disease, and polyarthritis. In adults it may lead to progressive renal insufficiency193; however, it can also be successfully treated. Acute hepatitis may be manifested in 10% to 20% of patients as a serum sickness­like illness with fever, skin rash, arthralgias, and polyarthritis, typically occurring just before the onset and subsiding with the development of jaundice. The skin rash can be of virtually any type, including erythematous, macular, maculopapular, urticarial, or petechial. The most common extrahepatic clinical manifestations of chronic hepatitis B include sensorimotor neuropathies, myalgias, arthralgias, Sjögren syndrome, glomerulonephritis, uveitis, and Raynaud syndrome. However, the risk of liver disease and overall mortality remains higher compared with those with either infection alone, even with effective virologic suppression. Recipients of bone marrow transplantations are also at risk of hepatitis B reactivation, which may present as a severe flare at the time of withdrawal of immunosuppression224 or as progressive chronic liver disease. In adults there are two groups of patients with chronic hepatitis B who do not need treatment but who should be monitored. These patients are in the inactive phase of chronic hepatitis B (previously known as "inactive carriers") and should have aminotransferases tested every 6 to 12 months to detect reactivation. The annual rate of reactivation is about 4%, with pre-C mutations, male sex, and age older than 30 years being predictors of reactivation. The threshold level that is associated with a risk of progression of chronic liver disease is not known. Medication lists should be reviewed, and patients should be reminded to avoid medications metabolized by the liver if possible or limit the doses. This is particularly true for agents such as acetaminophen, which patients may be taking to minimize discomfort and fever. Treatment of fulminant hepatitis is also supportive, including liver transplantation for those patients who do not appear to have spontaneous recovery. Treatment is also recommended for protracted severe acute hepatitis when increase in international normalized ratio and jaundice last for more than 4 weeks. In a meta-analysis the risk reduction for cirrhosis with antiviral treatment was 0. Other side effects seen after prolonged dosing include leukopenia and thrombocytopenia, hair loss, and changes in mood, including depression, which can be severe. Lamivudine is the negative enantiomer of 2,3dideoxy-3-thiacytidine (see Chapter 47). Dose reduction is necessary for patients with renal insufficiency (creatinine clearance [CrCl] < 50 mL/min). Resistance to lamivudine develops when used as monotherapy limiting the durability of response; thus it is not a recommended first-line agent (see "Viral Resistance" later). Lamivudine Chapter 145 Hepatitis B Virus Adefovir Nucleoside and Nucleotide Analogues Adefovir dipivoxil is the oral prodrug of adefovir, a phosphonate nucleotide analogue of adenosine monophosphate (see Chapter 47). Nephrotoxicity occurs in 3% of patients with compensated liver disease after 4 to 5 years of continued adefovir and in 47% of patients who underwent a liver transplant. Telbivudine is an l-nucleoside analogue that is structurally related to lamivudine (see Chapter 47) and thus has overlapping resistance patterns at the rtM204 position. However, due to relatively high rates of resistance and cross-resistance with lamivudine, it is not a first-line agent. These changes resulted from the development of resistance at rtM204I, which reached 25% at week 104. Mutations that confer resistance to lamivudine also confer resistance to emtricitabine (see Chapters 47 and 128). Combination therapy for hepatitis B is attractive because it may increase potency and decrease the rates for developing resistance; however, these concepts have not been clearly demonstrated to date, so combination therapy is not generally recommended. Resistance mutations differ based on the structural group of the drug, which include: l-nucleosides, d-cyclopentanes, and acyclic nucleotides. Cross-resistance occurs between agents in the same group and may decrease sensitivity between groups. In patients who are treatment naïve and do not have a preexisting rtM204V or rtL180M mutation, the rates of resistance are <1% per year with a 5-year cumulative rate of 1. Due to overlapping resistance mutations with lamivudine, lamivudine should be discontinued when entecavir is started, to theoretically decrease the risk for developing entecavir resistance. In patients with prior lamivudine-resistant mutations, cumulative incidence of adefovir dipivoxil resistance was higher-43% at 4 years. Serum aminotransferases may or may not become elevated, and there are rare instances of acute exacerbations and hepatic decompensation. If resistance occurs, current recommendations are to change therapy to the most effective agent that does not share cross-resistance. One study demonstrated that a triple mutant that occurs on lamivudine monotherapy (rtV173L/rtL180M/ rtM204V) leads to the surface changes sE164D/I195M. If a patient with a primary nonresponse is compliant, then resistance testing is appropriate to determine a change in the treatment strategy. The main causes of virologic breakthrough are noncompliance with therapy or viral resistance (see "Viral Resistance" earlier). The duration of therapy for most individuals is lifelong, but there are some patients for whom discontinuation of therapy can be considered. Both have been shown to suppress lamivudine-resistant variants298 and even resolution of graft failure in those patients who have them. In summary, with currently available combination therapy, survival is excellent in patients undergoing liver transplantation for chronic hepatitis B, even in those with active viral replication pretransplantation. Very few cases of reactivation have been reported with the use of immunosuppressants, including azathioprine and methotrexate. For patients receiving B-cell­depletion agents, therapy should be continue 12 to 18 months after the last dose, as reactivations as late as 17 months after completion of therapy have been reported. The guidelines also recommend that pregnant women in the immunoactive phase are managed the same as nonpregnant women, with the caveat that only drugs tested in pregnant women should be used. For example, patients should be counseled about the means of spread of delta hepatitis and hepatitis C to avoid superinfection with these viruses. Patients should also be counseled to consume minimal, if any alcohol, in the absence of data regarding safe levels of consumption and because consumption of large amounts of alcohol is clearly a risk factor for more rapid progression to cirrhosis. Until the immunization series is complete, sexual partners should use barrier methods. Both patients and contacts should be counseled regarding the modes of transmission and advised on methods to prevent household transmission, including avoiding sharing of items that might be contaminated with small amounts of blood, such as toothbrushes, and the need to cover open wounds. All treatment decisions need to take into consideration the risks and benefits for mother and fetus (potential exposure to teratogenic drugs). Despite high efficacy of recombinant vaccines, certain populations remain at risk of suboptimal or nonresponse to these vaccines (see "Efficacy"). Recently, the first and only two-dose hepatitis B vaccine, Heplisav-B, was approved for use in adults 18 years of age and older. In a subgroup analysis of 961 participants with type 2 diabetes, Heplisav-B demonstrated a statistically significantly higher rate of protection of 90% compared with 65% for Engerix-B. Universal vaccination of all infants has been recommended in the United States since 1991, and has since been adopted by many other countries and incorporated into routine childhood immunization programs. Vaccines should be administered intramuscularly because deposition of the vaccine into adipose tissue results in a lower seroconversion rate. The first vaccines were plasma derived and have now been completely replaced by recombinant vaccines. Although this was somewhat arbitrary, clinical studies suggest that a decrease in titer below this level is associated with a risk of infection. In persons receiving the newly approved Heplisav-B, 95% of patients exhibited a seroprotective response 8 weeks after the second dose of vaccine. Testing should be performed 1 to 2 months after the vaccine series in these individuals. After one to two doses, up to 25% of previous nonresponders or hyporesponders may have adequate titers. Another strategy is use of adjuvants as stimulators of immunogenicity of the vaccine, although studies show mixed results. Testing 1 to 2 months after vaccination is recommended for hemodialysis patients to determine their response to the vaccine. Complete protection was conferred for up to 22 years in those immunized as children and adults, and for up to 15 years in those immunized as infants. There is no evidence that cesarean section prevents maternal-infant transmission, and thus routine cesarean section is not recommended. The prevalence of these escape mutants is increasing over time, but the clinical and epidemiologic importance and the impact on current vaccination strategies are unclear. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. Long-term outcomes of entecavir therapy for chronic Hepatitis B after liver transplantation: results up to 8 years.

Syndromes

• Ankle and leg swelling
• Genetic testing 
• Damage to nerves due to surgery or trauma
• Osteonecrosis of the hip
• Inflexibility, extreme self-centeredness, inability to make a decision, or withdrawal from social interaction
• Breathing difficulty comes on suddenly or seriously interferes with your breathing
• Problems swallowing

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome treatment for uti bactrim ds generic 600 mg zyvox free shipping. Dromer F taking antibiotics for sinus infection zyvox 600 mg order with mastercard, Bernede-Bauduin C antibiotics for uti no alcohol 600 mg zyvox order overnight delivery, Guillemot D antibiotics ointment purchase zyvox 600 mg mastercard, et al; French Cryptococcosis Study Group bacteria yersinia enterocolitica generic zyvox 600 mg mastercard. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Disseminated histoplasmosis in the acquired immunodeficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Reevaluation of commercial reagents for detection of Histoplasma capsulatum antigen in urine. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. The National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Interferongamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Chapter 129 Management of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection 315. Recurrent Salmonella infection with a single strain in the acquired immunodeficiency syndrome: confirmation by plasmid fingerprinting. Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. Eradication of cryptosporidia and microsporidia following successful anti-retroviral therapy. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Altered clinical presentations and manifestations of early syphilis in patients with human immunodeficiency virus infection. A cluster of ocular syphilis cases-Seattle, Washington, and San Francisco, California, 2014­2015. Infections associated with Bartonella species in persons infected with human immunodeficiency virus. Bacillary angiomatosis: the histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Therapy · Pharmacologic therapies are directed at relieving symptoms of pain, sleep disruption, and depression. The available evidence favors the notion that the syndromal definition identifies a heterogeneous population of patients in whom fatigue, pain, cognitive complaints, and viral-like symptoms, such as low-grade fever, sore throat, and tender lymph nodes, are the final common consequences of a variety of different causes. The current, prevailing etiologic hypothesis is that the disorder is a multifactorial condition in which genetic and environmental factors (including infection) interact to produce a disturbed capacity to manage and to control stress, fatigue, and pain. Most authorities in the United States preferred the designation chronic fatigue syndrome because it is defined by the clinical features of the illness without implication of a specific etiology or characteristic pathology. Postviral fatigue and postinfectious fatigue are less strictly defined designations for chronic idiopathic fatigue when the condition is perceived to be induced by an infectious disease and persists after resolution of the infection. The illness has been attributed variously to neurologic, cardiovascular, endocrine, and infectious causes. The proximate association of infections, especially influenza, with chronic fatigue. He hypothesized that the development of "chronic brucellosis" involved an infection and a psychological predisposition. Prolonged convalescence from influenza was correlated with preexisting, unfavorable scores on certain subscales of this test. The evidence that active infection with any of these agents causes a significant proportion of chronic fatigue cases is either inconclusive or refuted by subsequent investigations. Better understanding by physicians and the public and less encumbrance of research by multiple case definitions should follow. Fatigue is one of the most common complaints encountered in general medical practice. In most patients the complaint is eventually attributed to a diagnosable medical condition or is short lived. According to the most recent consensus conference definition, severe fatigue that remains unexplained after baseline physical and laboratory examinations and persists for more than 6 months is designated as idiopathic chronic fatigue. Patients with idiopathic chronic fatigue who also complain of four or more of the associated symptoms listed in Table 130. In a general medical practice in Boston, idiopathic chronic fatigue was reported by 8. The prevalence, age, and sex distribution were remarkably similar in the four cities. Patients were predominantly women (7: 1) and clustered in the 30- to 50-year age group. When a random telephone survey was conducted in the San Francisco area, a different epidemiologic pattern emerged. A substantial reduction or impairment in the ability to engage in preillness levels of occupational, educational, social, or personal activities; that persists for more than 6 months and is accompanied by fatigue, which is often profound; is of new or definite onset (not lifelong); is not the result of ongoing excessive exertion, and is not substantially alleviated by rest and 2. Unrefreshing sleepa At least one of the two following manifestations is also required: 1. The diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome should be questioned if patients do not have these symptoms at least half of the time with moderate, substantial, or severe intensity. The age distribution was the same as that seen in clinic-based studies, but the distribution of cases by income showed higher rates in persons with family incomes less than $40,000, suggesting that the perception of "yuppie flu" is an artifact of health care use by the affected populations. Of interest, female gender comparable to that seen in adults appeared among 16-year-olds but not 13-year-olds. Large hospital outbreaks in Los Angeles and London affected the professional staff but not the hospitalized patients or nonprofessional staff. A 10-year follow-up of these cases indicated that most patients had recovered partially or completely. Foremost among these is the problem of selecting a homogeneous group of subjects for study from among patients identified by the working definition. Most patients have past or current psychiatric disorders,38­40 whereas some have no past or present psychiatric symptoms. Others have reported that postinfectious and idiopathic cases have indistinguishable clinical and psychosocial features. Controversy persists about whether chronic fatigue can be triggered by any infectious or traumatic event or whether only a particular type of infection or trauma is necessary. However, patients seen in general practice for common infections do not have an increased frequency of prolonged fatigue relative to patients seen for other medical problems. However, like many similar virologic observations, it is not clear whether persistent enterovirus is a cause or a consequence of the syndrome. These investigators proposed that the persistent fatigue may be attributable to neurally mediated hypotension. Resting catecholamine levels are increased, and thermoregulatory responses suggest increased sympathetic activation at rest. Although subtle alterations in some of these systems have been identified in patients, similar changes are observed in individuals without symptoms. One prospective study of postinfectious fatigue failed to find any significant differences in the levels of eight cytokines comparing patients and control subjects. Analysis of cancer registries after the large 1985 Lake Tahoe outbreak did not support this notion. This study and a subsequent trial suggest that there was minor improvement in the hydrocortisone group during treatment. This suggests that any fundamental disturbance occurs at a more complex level in the brain. However, the clonidine-treated patient also had fewer steps per day, suggesting that pharmacologic reduction of sympathetic outflow did not increase physical activity. As in the earlier studies of brucellosis and influenza by Imboden and coworkers,7 contemporary investigators have found that when patients present with a "viral illnesses" in general practice, psychiatric morbidity, belief in vulnerability to viruses, and attributional style at initial presentation are more important predictors of fatigue 6 months later than are "viral" symptoms during the initial infection. Cohorts born in 1946, 1958, and 1970 were analyzed in separate studies that came to similar conclusions. The study found that those with psychopathology assessed by standard interview instruments at ages 15 and 36 years were 2. Polymorphisms in this gene have previously been associated with a variety of psychiatric disorders. Nevertheless, research on related disorders provides strong evidence for genetic predisposition in similar functional disorders. These symptoms include sore throat, low-grade fever, tender adenopathy, generalized myalgia, migratory arthralgia, and headache. In contrast, objective physical findings corresponding to these subjective complaints, such as pharyngitis, a temperature greater than 100. The presence of significant objective muscle weakness or frank arthritis should suggest an alternative diagnosis. Patients often report that they have a limited allotment of energy each day and cannot function when it is depleted. In consequence, Wessely and Powell130 undertook a prospective study using standardized interview instruments to compare the perception of fatigue among patients with "postviral fatigue" and control groups with neuromuscular disorders or major depression. They determined that the features of physical fatigue were similar in all three groups, but complaints of mental fatigue. Patients may describe difficulty with concentration and memory, although actual deficits are not consistently demonstrable using neuropsychological testing. A thorough sleep history helps to determine whether formal polysomnography is indicated to rule out a primary sleep disorder. Several of these disorders may occur in the same patient, and their concurrence may reflect our inability to adequately understand or define them. A unified view of etiology and management of these disorders is presented in a review by Henningsen and coworkers. Laboratory evaluation requires testing only for the purpose of ruling out unrecognized medical 1792 conditions that account for the symptoms. The minimal evaluation consists of a complete blood count, serum chemistry profile, urinalysis, and thyroid function testing. Instead, antibodies directed against insoluble nuclear matrix proteins are responsible for the nuclear fluorescence. These findings may provide some insight into the pathophysiology of chronic fatigue states, but they have no diagnostic value in individual patients. In all of these examples there is significant overlap between the fatigued and normal groups, and the tests cannot be used as a reliable marker for the disorder in an individual. Levels should be obtained only when clinical findings indicate a need to rule out frank adrenal insufficiency. The causes of these findings are unknown, and their relationship to symptoms is not clear. Laboratory evaluation of the 2,5-oligoadenylate synthetase pathway86 is not sufficiently specific to be helpful in diagnosis. Also, noncontrolled treatment observations are of minimal value in these disorders because most blinded controlled trials have shown a robust placebo effect. It is useful to objectify the symptoms as much as possible so that the response to any intervention can be assessed independently by both the physician and the patient. Medications should be evaluated in an additive or sequential manner so that there can be no confusion about their efficacy or adverse effects. With the large range of symptoms among these patients, physicians are faced with a variety of treatments from which to choose, and patients may inquire about unconventional or alternative therapies. In the absence of evidence for efficacy, empirical treatment choices should be guided by a concern for safety and cost. Medications may be useful for the treatment of symptoms, including nonnarcotic pain relievers for myalgia, arthralgia, or headache; nonaddictive sleep aids for sleep disruption; and psychoactive agents for depression or anxiety. Various vitamins and "nutritional supplements" have no proven, consistent benefit and may be costly. Carefully controlled treatment trials do not show a consistent benefit from any single pharmacologic agent.

Epidemiological studies in smallpox: a study of intrafamilial transmission in a series of 254 infected families antibiotics for feline acne zyvox 600 mg purchase online. Quantitative investigations on the spread of virus through the host in actively and passively immunized animals 3m antimicrobial foam mouse pad zyvox 600 mg buy overnight delivery. Immunologic responses to vaccinia vaccines administered by different parenteral routes antibiotics for mild uti 600 mg zyvox overnight delivery. Complications of smallpox vaccination antibiotic resistance threats in the united states 2015 zyvox 600 mg order amex, 1968: national surveillance in the United States antibiotics nephrotoxicity discount zyvox 600 mg free shipping. Fatal generalized vaccinia with failure of antibody production and absence of serum gamma globulin. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. Demonstration of vaccinia virus antigen in brains of postvaccinal encephalitis cases. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Chapter 132 Orthopoxviruses Vaccinia (Smallpox Vaccine), Variola (Smallpox), Monkeypox, and Cowpox 1817. Update: adverse events following civilian smallpox vaccination- United States, 2003. Update on cardiac and other adverse events following civilian smallpox vaccination-United States, 2003. Focal and generalized folliculitis following smallpox vaccination among vaccinia-naïve recipients. Virological investigations of specimens from buffaloes affected by buffalopox in Maharashtra State, India between 1985 and 1987. Advances in Medical and Veterinary Virology, Immunology and Epidemiology: Cultivation and Immunological Studies on Pox Groups of Viruses With Special Reference to Buffalo Pox Virus. Detection of poxvirus in cattle associated with human cases in the state of Rio de Janeiro: preliminary report. Short report: isolation of two vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: implications on the emergence of zoonotic orthopoxviruses. Detection and molecular characterization of zoonotic poxviruses circulating in the Amazon Region of Colombia, 2014. Update: multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus. Gene for A-type inclusion body protein is useful for a polymerase chain reaction assay to differentiate orthopoxviruses. Detection and differentiation of Old World orthopoxviruses: restriction length polymorphism of the crmB gene region. Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. Prevalence of antibodies against orthopoxviruses among residents of Likouala region, Republic of Congo: evidence for monkeypox virus exposure. Investigation of the first laboratory-acquired human cowpox virus infection in the United States. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication. The antiviral and synergistic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice. The laboratory and clinical assessment of an iso-thiazole thiosemicarbazone (M&B 7714) against pox viruses. Effect of 5-iodo-2deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice. Efficacy of multiple or single dose cidofovir against vaccinia and cowpox virus infections in mice. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug. Efficacy of 2-amino-7-(1,3dihydroxy-2-propoxymethyl) purine for treatment of vaccinia virus (orthopoxvirus) infections in mice. Effect of cytosine arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatode-oxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. Pathogenesis and potential antiviral therapy of complications of smallpox vaccination. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Chapter 132 Orthopoxviruses Vaccinia (Smallpox Vaccine), Variola (Smallpox), Monkeypox, and Cowpox 133 Definition Other Poxviruses That Infect Humans: Parapoxviruses (Including Orf Virus), Molluscum Contagiosum, and Yatapoxviruses Brett W. Epidemiology · Parapoxvirus infections most commonly occur in individuals with occupational exposures to infected sheep, cattle, or goats. Diagnosis · Parapoxvirus, molluscum contagiosum, and yatapoxvirus infections are often diagnosed clinically based on their characteristic clinical features in combination with appropriate exposure and travel histories. Prevention Therapy · Transmission of parapoxviruses, molluscum contagiosum, and yatapoxviruses can be prevented by avoiding exposures to animal vectors, properly covering lesions, and observing good hand hygiene practices. Human infection, characterized by localized epithelial lesions, is an occupational hazard for people who handle infected animals. Parapoxvirus infection in sheep and goats is usually referred to as sore mouth, scabby mouth, contagious pustular dermatitis/ ecthyma, or orf, and the corresponding human infection is referred to as orf. Taxonomically the relevant parapoxvirus species is referred to as Orf virus; synonyms are contagious pustular dermatitis virus and contagious ecthyma virus. The parapoxvirus species associated with beef cattle is referred to as bovine papular stomatitis virus. Other zoonotic infections caused by tentative members of the Parapoxvirus genus and shown to infect humans are derived from camel exposure (contagious ecthyma or Ausdyk disease) or, less often, from seals (sealpox) and deer. Lesions in animals are found on the skin, in the oropharyngeal mucosa, and on external surfaces. Other parapoxviruses documented to cause ungulate, pinniped, or other nonhuman animal infections may also cause human illness. In addition, members of the Parapoxvirus genus have a characteristic M form that can be observed with negative-stain electron microscopy: one long spicule wraps the particle, giving a crisscross effect. Complete genome sequences of Orf virus and bovine papular stomatitis virus have been reported. Most a Infection, which occurs via cuts and scratches, usually remains localized in the epithelium or oral mucosa. Human lesions of orf are produced by hypertrophy and proliferation of epidermal cells, which is often marked and perhaps related to the endothelial growth factor homologue encoded by the virus and to leukocyte infiltration. Histologic examination of human lesions shows many small multilocular vesicles within the dermis; true macrovesicles rarely occur. Six stages of clinical disease are 1818 1819 In most cases, the disease is self-limited. Anecdotal reports of the use of 3% cidofovir topical cream32,33 have described apparent beneficial effects; however, no controlled trials are available. Topical treatment with the Toll-like receptor/interferon modulating compound imiquimod has also shown benefit in a number of cases,34,35 including the case of a patient with a giant orf lesion that failed to respond to topical and intralesional cidofovir. Nodule caused by orf virus after contact with a lamb being sacrificed for a holiday-Massachusetts 2010. After a brief incubation period of 3 to 5 days, lesions begin as (pruritic) erythematous macules and then raise to form papules, often with a target appearance (days 7­14). Lesions become nodular or vesicular, and orf lesions often ulcerate after 14 to 21 days; this ulceration has been referred to as the acute stage. Complete healing can take 4 to 6 weeks and is characterized by a regenerative papilloma and regressive stages where normal epithelium is seen once again. Parapoxvirus infections reported in handlers of reindeer and musk-oxen in Norway are more granulomatous and persist for months. Polymerase chain reaction diagnostic tests generic for parapoxvirus24,25 and orf25,26 have been reported; however, the infection is usually clinically diagnosed on the basis of exposure history and the presence of a characteristic lesion. Negative-stain transmission microscopy of lesion material examined by a skilled observer can be diagnostic if the characteristic structure is observed. Virus isolation in tissue culture usually requires primary ovine or bovine cells and may be difficult to attain. Human orf infection is most common in the spring, a time when the bottle-feeding of lambs may predispose humans to exposure risks, and in the fall, when slaughtering and shearing occur. Infected individuals should take care not to further infect themselves with autoinoculation or to spread infection to contacts, including animals. The vaccine used to control orf in sheep is fully virulent and has caused human infection. Four subtypes, characterized by restriction endonuclease digests, have been described. Molluscum contagiosum lesions have long been known to have a distinctive pathology. In 1841 the first description of characteristic molluscum bodies-Henderson-Paterson bodies-was provided by Henderson and Paterson. Onset of infection occurs when the virus begins replication in the lower layers of the epidermis42 and then extends upward. The incubation period is quite variable and can be lengthy (2­7 weeks; as long as 6 months has been suggested). Characteristic inclusions (Henderson-Paterson bodies, or molluscum bodies) are formed in the prickle cell layer and gradually enlarge as cells age and migrate to the surface. The structure of the basement membrane remains intact; the hypertrophied epidermal cells, with their cytoplasm occupied by a large acidophilic granular mass (the molluscum body), project above the skin to appear as a tumor. A cheesy off-white, sometimes yellowish, material is easily expressed from lesions. Because of multiple simultaneous infections, or mechanical spread, these lesions may become confluent along the line of a scratch, and satellite lesions are occasionally seen. In adults, they tend to occur on the trunk, pubic area, and thighs, but in all cases, infection may be transmitted to other parts with autoinoculation. Brick-shaped virions can usually be seen in large numbers if the cheesy material expressed from the lesion is examined with transmission negative-stain electron microscopy. The virus has 1820 Human infection with tanapox virus, which was first recognized in the Tana River basin area of Kenya in 1957, was best characterized during post­smallpox eradication surveillance efforts. An account of 264 laboratory-confirmed cases from Zaire (now the Democratic Republic of Congo), with color illustrations, is available,64 as is information on the virus itself. The papule then becomes more "pocklike" but contains no fluid; umbilication or the formation of a pseudocrust has been reported at this stage. At the end of the first week, the lesion is surrounded by erythema and by indurated skin. After this stage, lesions either ulcerate or become larger nodules, up to 2 cm in diameter. In the African series, maximum size was usually reached within 2 weeks, and then the local inflammatory response began to wane and the lesion began to granulate. The most common location for lesions (72%) is the lower extremities, and the least common locations are the face and parts of the body that are normally covered by clothing. The characteristic histopathology of these lesions is diagnostic; polymerase chain reaction methods have been described. Traditional modes of transmission are associated with mild skin trauma and in some cases fomites (shared towels). Among adults the disease is often sexually transmitted, and genital lesions are common. Covering of lesions and hand hygiene after contact with lesions should prevent transmission in these situations. Infection is benign and recovery is usually spontaneous, but treatment may be sought for cosmetic reasons, particularly for facial or multiple lesions. Various treatments have been tried37 including cryotherapy,54 mechanical curettage,54,55 and chemical treatments (podophyllin/ podofilox, cantharidin, iodine, and tretinoin). Topical application of an antiviral 3% cidofovir cream or suspension58,59 has been reported to be beneficial, as has potentially immune-modulating cimetidine. A retrospective medical chart review and telephone survey failed to show a beneficial effect of any therapy compared with no therapy on time to clearance or rate of recurrence of lesions. Diagnosis Therapy For diagnosis of tanapox, the limited geographic distribution should be considered, as should travel history. Unique clinical features that allow the differentiation of tanapox from other orthopoxvirus infections include the nodular nature of the rash lesion, local adenopathy, paucity of lesions, benign disease course, and protracted course of rash resolution.

Randomized phase 2 trial of the oncolytic virus pelareorep (reolysin) in upfront treatment of metastatic pancreatic adenocarcinoma treatment for demodex dogs cheap zyvox master card. Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation antimicrobial medications list purchase 600 mg zyvox fast delivery. Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial antibiotics after root canal discount 600 mg zyvox free shipping. Yellow fever in the Gambia antibiotics for uti first trimester buy zyvox 600 mg free shipping, 1978-1979: epidemiologic aspects with observations on the occurrence of Orungo virus infections infection toe cheap zyvox online amex. Review of the 2012 epizootic hemorrhagic disease outbreak in domestic ruminants in the United States. Chapter 148 Orthoreoviruses and Orbiviruses 149 Coltiviruses (Colorado Tick Fever Virus) and Seadornaviruses Daniel M. Cerebrospinal fluid analysis may show a lymphocytic pleocytosis with mildly elevated protein and near-normal glucose. Diagnosis genera of the Reoviridae virus family that have been documented to cause human disease. Several other novel seadornaviruses have also been identified, though none are known to cause human disease. Coltivirus and Seadornavirus are two of five genera of the Reoviridae virus family that have been documented to cause human disease; Orthoreovirus, Orbivirus, and Rotavirus genera are discussed in Chapters 148 and 150. Coltiviruses were classified within the Orbivirus genus until 1991, at which time their distinct molecular identity was established and a unique genus was proposed. Coltiviruses were initially subclassified into the tick-borne subgroup A (North American and European distribution) and mosquito-borne subgroup B (Asian distribution) viruses. Two additional cases were reported from Colorado with unknown county of residence. Distribution, seasonality, and hosts of the Rocky Mountain wood tick in the United States. Sore throat, nausea, vomiting, abdominal pain, arthralgia, neck pain or stiffness, and/or rash (either maculopapular or petechial) can also occur. Neurologic complications such as meningitis and encephalitis can rarely occur, especially in children. For those with meningitis or encephalitis, cerebrospinal fluid analysis can show a lymphocytic pleocytosis with mild elevation of protein and near-normal glucose. Death is rare, often being associated with disseminated intravascular coagulation or meningoencephalitis in children. Aspirin should be avoided because it may exacerbate the potential for hemorrhage associated with thrombocytopenia. Patients with severe symptoms may need to be hospitalized for rehydration and symptom management. People outdoors in endemic areas should use insect repellent on exposed skin, wear long-sleeved shirts and pants when feasible, avoid walking through high-brush areas, and perform tick checks once inside. Its ecologic cycle is not fully known, though its amplifying host is thought to be the European rabbit, and serosurveys have found Eyach virus­ specific antibodies in rodents, sheep, goats, and deer in parts of Europe. There is no specific known treatment for Banna virus disease other than supportive care. Mosquito-bite prevention strategies such as applying insect repellent when outdoors, wearing long-sleeved shirts and pants when feasible, and using window screens or air conditioning when indoors may help prevent infection in endemic areas. Colorado tick fever: isolation of the virus from Dermacentor andersoni in nature and a laboratory study of the transmission of the virus in the tick. Replication of Colorado tick fever virus within human hematopoietic progenitor cells. Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances. Genus Coltivirus (family Reoviridae): genomic and morphologic characterization of Old World and New World viruses. Sequence determination and analysis of the full-length genome of Colorado tick fever virus, the type species of genus Coltivirus (family Reoviridae). Complete sequence determination and genetic analysis of Banna virus and Kadipiro virus: proposal for assignment to a new genus (Seadornavirus) within the family Reoviridae. Comparative sequence analysis of American, European and Asian isolates of viruses in the genus Coltivirus. Eyach: an arthropod-borne virus related to Colorado tick fever virus in the Federal Republic of Germany. Erve and Eyach: two viruses isolated in France, neuropathogenic for man and widely distributed in Western Europe. New orbiviruses isolated from patients with unknown fever and encephalitis in Yunnan province. Structural organization of an encephalitic human isolate of Banna virus (genus Seadornavirus, family Reoviridae). Liao ning virus, a new Chinese seadornavirus that replicates in transformed and embryonic mammalian cells. Isolation and genetic characterization of Mangshi virus: a newly discovered Seadornavirus of the Reoviridae family found in Yunnan province, China. Epidemiology Viral Structure and Replication · the viral particle is a triple-layered icosahedron. Therapy · Therapy is primarily supportive and aimed at maintaining hydration until the infection resolves. Immunity Immunization Clinical Manifestations · Gastroenteritis due to rotavirus is not readily distinguished from gastroenteritis caused by other agents on clinical grounds alone. Pathogenesis · the virus primarily infects epithelial cells at the tips of the intestinal villi. Serologic Classification · Most rotaviruses that cause human disease are in group A. Diagnosis · Specific virologic diagnosis is not necessary for routine clinical care but is useful for epidemiologic study, in complicated or prolonged cases, and to reduce unnecessary antibiotic use. The family Reoviridae also includes reoviruses, which have occasionally been isolated from patients with respiratory illnesses but have not been established as a cause of human disease, and coltiviruses and seadornaviruses, which cause disease in humans (see Chapters 148 and 149). Rotaviruses are the most important cause of severe dehydrating gastroenteritis in children younger than 5 years in all socioeconomic groups and in all regions of the world. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. In 1973 electron microscopic examination of duodenal biopsy specimens from six of nine children with acute gastroenteritis revealed similar viral particles, which were approximately 70 nm in diameter. The antigenic similarity between the human and bovine agents was confirmed when an exchange of matched liquid stool samples and convalescent sera between a veterinary and a medical laboratory showed that antibodies in the sera of children and calves agglutinated the rotavirus particles in the stools of both species. These vaccines greatly reduced the health impact of rotaviruses in the upper- and middle-income countries where they were first introduced, with evidence of both direct vaccine-elicited immunity and a herd effect. The ability to "mate" rotavirus strains by coinfecting cells to achieve reassortment of the 11 genome segments has allowed classic genetic studies. Extensive global epidemiology has relied on elaborate serology, now supplemented by nucleic acid­based diagnostics. Each genome segment contains one or, in the case of genome segment 11, two open reading frames. Chapter 150 Rotaviruses Inactivation the rotavirus particle is physically hardy and resists inactivation by treatment with fluorocarbons, ether, and concentrations of chlorine typically used to treat sewage effluent and drinking water. Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests. For example, those who are secretor negative appear to be resistant to disease caused by P8 rotaviruses and at lower overall risk of severe rotavirus gastroenteritis in the United States, where P8 rotaviruses are prevalent. The mechanism of selective packaging remains obscure but may involve base-pairing interactions between the nascent genome segments; the mechanism of genome sequestration is better understood. In some neonatal nurseries, difficult-to-eradicate endemic rotavirus strains asymptomatically infect neonates year round. Because outbreaks of rotavirus diarrhea in neonatal nurseries also occur, any component of maturational resistance cannot be absolute. In one such study 4 of 18 adult volunteers developed vomiting 1 to 3 days after oral administration of a virulent rotavirus strain. Two-thirds of the adult volunteers developed serologic evidence of infection without disease. Similarly, most naturally occurring rotavirus infections of adults are asymptomatic, manifested only by a rise in antibody titer. Vomiting is more common and prolonged with rotavirus gastroenteritis than with pediatric gastroenteritis caused by most other agents. Conditions associated with chronic rotavirus infection include X-linked agammaglobulinemia, cartilage hair hypoplasia, and DiGeorge syndrome. Although some strains of rotavirus can cause biliary atresia in mouse models, and group C rotavirus has been detected in liver tissue from biliary atresia patients, rotavirus has not been convincingly demonstrated to cause this condition in humans. Human Intestinal Enteroid Infection Model the severity of diarrhea in children with rotavirus gastroenteritis correlates with the degree of mucosal damage, which suggests that malabsorption related to loss of absorptive cells may contribute to rotavirus diarrhea late in infection. In several animal models, rotavirus infection induces a net secretion of fluid, sodium, and chloride from intestinal segments. Treatment of rotavirus-infected mice with lidocaine (a sodium channel­ blocking anesthetic), ondansetron or granisetron (serotonin receptor antagonists), or a vasoactive intestinal peptide receptor antagonist attenuates diarrhea. Rotavirus strains have been classified serologically into serogroups, subgroups, G serotypes, and P serotypes, and genetically into electropherotypes, species, genogroups, G genotypes, and P genotypes. Historically, groups have been defined serologically, based on the cross-recognition of rotavirus particles by serum antibody obtained from parenterally hyperimmunized animals. Group A is the most important clinically, as group A viruses cause the endemic gastroenteritis of children; groups B and C have been associated with epidemics of gastroenteritis affecting all ages. Rotavirus whole-genome analysis indicates that there are two main genogroups of human group A rotaviruses, each of which contains viruses with overall genome similarity. At the time of vaccine introduction, five G types (G1­4 and G9) comprised 88% of human rotavirus isolates. For example, G8 rotavirus strains are prevalent in high-rotavirus-mortality countries in Africa and therefore have more clinical significance than their global prevalence would suggest. Unlike G serotypes, which have a one-to-one correspondence with G genotypes, some P serotypes include more than one P genotype. In strain descriptions the genotype is enclosed in brackets after the serotype designation. Reassortment between human and animal rotavirus strains, antigenic drift, and the occasional introduction of animal rotaviruses into the pool of viruses circulating among humans provide a continuous introduction of genetic diversity, necessitating ongoing surveillance to determine whether rotavirus vaccines will require strain changes in the future for continued efficacy. As of 2016 rotavirus remained the most common cause of severe dehydrating diarrhea in infants and children younger than 5 years in low-, middle-, and high-income countries, responsible for approximately 28. Before the introduction of rotavirus vaccines in 2006, rotavirus was a major cause of morbidity and health care costs in developed countries. For example, in the prevaccine era in the United States, approximately 3 million cases of childhood rotavirus gastroenteritis were responsible for approximately 735,000 physician visits, 27,000 hospitalizations, 20 to 40 deaths, $319 million in direct health care costs, and $893 million in total economic costs to society each year. In a single region the dominant strains differ from year to year; in the same year the dominant strains differ regionally. Experiments on the transmission of rotavirus gastroenteritis (epizootic diarrhea of infant mice) between cages of mice support the possibility of airborne spread. Rotavirus outbreaks have occurred in nursing home populations and sometimes have resulted in fatalities. In addition to the remote shared ancestry of major human and nonhuman animal rotavirus lineages, there is evidence of low-level ongoing zoonotic rotavirus disease. The evidence that breastfeeding protects human infants from rotavirus diarrhea is mixed, with a meta-analysis of the literature showing no significant correlation between breastfeeding and rotavirus gastroenteritis. Protection after natural infection appears to be somewhat more reliable against viruses of the same G type as the infecting strain. The observation that natural rotavirus infection, whether symptomatic or asymptomatic, provides partial protection from subsequent episodes of rotavirus gastroenteritis guided the development of the current generation of vaccines. For example, asymptomatic infection of neonates with nursery strains of rotavirus protects against subsequent severe rotavirus gastroenteritis but not against asymptomatic reinfection or mild-to-moderate disease. Protection from subsequent moderate or severe rotavirus diarrhea was 87% after one natural infection of any severity and 100% after two natural infections. Rather, repeated asymptomatic or mildly symptomatic episodes of rotavirus gastroenteritis throughout life appear to be important for maintaining immunity. Protection by Antibody the mechanisms of rotavirus neutralization have been examined in detail using mouse-derived monoclonal antibodies. These antibodies do not neutralize intact virions in cell culture but do protect mice from rotavirus infection when secreted into the serum by "backpack" hybridoma tumors. Innate responses to rotavirus are essential triggers for the humoral immune response. Because the standard treatment for rotavirus gastroenteritis is rehydration and supportive care, a specific microbiologic diagnosis is not required in most cases. However, with prolonged diarrhea, in complicated cases, in immunocompromised hosts, when alternative diagnoses are considered, or when epidemiologic or infection control data are needed, it may be desirable to establish rotavirus as the etiologic agent. Definitively diagnosing rotavirus gastroenteritis may also prevent the unnecessary and potentially harmful use of antibiotics. Although some randomized clinical trials indicate that the addition of racecadotril can decrease mean stool output in inpatients and the mean number of diarrheic stools in outpatients, two randomized, double-blind, placebocontrolled clinical trials in India showed no significant effect. Because of complications including ileus and respiratory depression, antimotility agents such as loperamide have no role in the treatment of childhood gastroenteritis. Because rotavirus gastroenteritis is generally self-limited, and dehydration is the primary cause of morbidity and mortality, rehydration and restoration of electrolyte balance are the primary therapies. The low-osmolarity formulation is 75 mM sodium, 20 mM potassium, 65 mM chloride, 10 mM citrate, and 75 mM glucose (see reference for acceptable variations).

600 mg zyvox order overnight delivery. 6 Things That Happen When You Eat A Spoonful Of Coconut Oil Everyday.

References

• Kumar V, Pena de la Vega L, Farell G, et al: Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers, Kidney Int 68:1784n1792, 2005.
• Krystal AD, Preudihomme XA, Amundsen CL, et al: Detrusor overactivity persisiting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study, J Urol 184:623n628, 2010.
• MacDonald P, Alexander D, Catz C, et al: Summary of a workshop on maternal genitourinary infections and the outcome of pregnancy, J Infect Dis 147(3):596-605, 1983.
• Michalski D, Liebig S, homae E, Hinz A, Bergh FT. Pain in patients with multiple sclerosis: a complex assessment including quantitative and qualitative measurements provides for a disease-related biopsychosocial pain model. J Pain Res 2011;4: 219-225.
• Egeler RM, de Kraker J, Voute PA. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol 1993; 21(4):265-270.
• Kraus VB, Kepler TB, Stabler T, Renner J, Jordan J. First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS One 2010; 5(3):e9739.